AMRH - アメリ・ホ―ルディングス (Ameri Holdings Inc.) アメリ・ホ―ルディングス

 AMRHのチャート


 AMRHの企業情報

symbol AMRH
会社名 Ameri Holdings Inc (アメリ・ホ―ルディングス)
分野(sector) Technology   ハイテク
産業(industry) Semiconductors  
業種 ITサ―ビス_コンサルティング   IT・通信(IT_Communications)
概要 事業概要 Ameri Holdings Inc. is a provider of consulting services and technology solutions. The Company delivers a range of solutions and services across various industries including banking financial services and insurance. Its services include strategic consulting digital transformation services robotics process automation (RPA) and co-creation of customized solutions including those in mobility sustainability big data and cloud computing. Its services and solutions include enterprise architecture enterprise resource planning (ERP) predictive analytics and enterprise mobility. Its products include Simple APO application Integrated Business Planning (IBP)/Sales and Operations Planning (S&OP) Mobile Analytics application and The Langer Index. Its ERP solutions include ERP consultancy design implementation and solutions based on industry practices migration upgrades rollout mobility maintenance and support and managed services.   アメリ・ホ―ルディングスは米国のITサ―ビス持株会社。子会社を通じて、クラウドおよびデジタル、企業向けサ―ビスを提供する。クラウドコンピュ―ティングを利用しアプリケ―ションを構築してホストするクラウド部門、モバイル・ソリュ―ション部門、ビジネス分析ソリュ―ションを提供するエンタ―プライズ部門から構成される。本社所在地はニュ―ジャ―ジ―州プリンストン。   Ameri Holdings, Inc. is a technology services company, which specializes in systems, applications, and products (SAP) cloud, digital, and enterprise services. It offers technology consulting; business intelligence; cloud services; application development, integration, and maintenance; implementation services; infrastructure services; and independent validation services. The company was founded by Srinidhi Devanur in February 1994 and is headquartered in Suwanee, GA.
本社所在地 100 Canal Pointe Boulevard Suite 108 Princeton NJ 08540 USA
代表者氏名 Jeffrey E. Eberwein ジェフリーE.エバーウェイン
代表者役職名 Chairman of the Board 取締役会会長
電話番号 +1 770-935-4152
設立年月日 34366
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 237人
url www.spatializer.com
nasdaq_url https://www.nasdaq.com/symbol/amrh
adr_tso
EBITDA EBITDA(百万ドル) -6.70443
終値(lastsale) 1.23
時価総額(marketcap) 28134339.81
時価総額 時価総額(百万ドル) 28.24871
売上高 売上高(百万ドル) 46.12338
企業価値(EV) 企業価値(EV)(百万ドル) 32.26376
当期純利益 当期純利益(百万ドル) -9.65134
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Ameri Holdings Inc revenues decreased 10% to $22.1M. Net loss applicable to common stockholders decreased 30% to $3.5M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Acquisition related expenses decrease of 97% to $10K (expense) Other income increase of 79% to $8K (income).

 AMRHのテクニカル分析


 AMRHのニュース

   AMERI Holdings Announces Pricing Of $1.725 Million Registered Direct Offering Priced At-The-Market  2020/06/03 12:30:00 PR Newswire
ATLANTA, June 3, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) (the "Company"), today announced that it has entered into a securities purchase agreement with institutional investors to purchase approximately $1.725 million of its common shares in a registered direct offering…
   AMERI Holdings Amalgamation Partner Jay Pharma Reports IRB Approval For Testing Proprietary CBD Formulation In Brain Cancer  2020/06/02 13:00:00 PR Newswire
ATLANTA, June 2, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) (the "Company"), today announced that its proposed amalgamation partner Jay Pharma Inc. ("Jay Pharma") received institutional review board ("IRB") approval by Rabin Medical Center in Petah Tikva, Israel for a Phase…
   Jay Pharma Details Business and Clinical Trials Strategy  2020/02/27 13:00:00 PR Newswire
ATLANTA, Feb. 27, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) (the "Company"), brings to the attention of its shareholders a Letter to Stakeholders and Investor Presentation published by Jay Pharma Inc. ("Jay Pharma") that provides an overview of the Company's commitment to…
   Jay Pharma Appoints Former Mallinckrodt plc Executive as Audit Committee Chair  2020/02/20 13:00:00 PR Newswire
ATLANTA, Feb. 20, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) (the "Company"), brings to the attention of its shareholders a press release issued by Jay Pharma Inc. ("Jay Pharma") today to announce the appointment of George A. Kegler, Jr. to Jay Pharma's Board of Directors…
   Sara Dakar to Join Jay Pharma as Vice President, Product Development  2020/02/18 14:00:00 PR Newswire
ATLANTA, Feb. 18, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) (the "Company"), brings to the attention of its shareholders a press release issued by Jay Pharma Inc. ("Jay Pharma") today to announce the appointment of Sara Dakar as Vice President, Product Development. In her…
   Jay Pharma Details Business and Clinical Trials Strategy  2020/02/27 13:00:00 PR Newswire
ATLANTA, Feb. 27, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) (the "Company"), brings to the attention of its shareholders a Letter to Stakeholders and Investor Presentation published by Jay Pharma Inc. ("Jay Pharma") that provides an overview of the Company's commitment to…
   Jay Pharma Appoints Former Mallinckrodt plc Executive as Audit Committee Chair  2020/02/20 13:00:00 PR Newswire
ATLANTA, Feb. 20, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) (the "Company"), brings to the attention of its shareholders a press release issued by Jay Pharma Inc. ("Jay Pharma") today to announce the appointment of George A. Kegler, Jr. to Jay Pharma's Board of Directors…
   Sara Dakar to Join Jay Pharma as Vice President, Product Development  2020/02/18 14:00:00 PR Newswire
ATLANTA, Feb. 18, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) (the "Company"), brings to the attention of its shareholders a press release issued by Jay Pharma Inc. ("Jay Pharma") today to announce the appointment of Sara Dakar as Vice President, Product Development. In her…
   Former CIA Director R. James Woolsey Joins AMERI Holdings As Strategy Consultant, Expects To Join Jay Pharma Board Of Directors Upon Closing Of Merger  2020/01/27 13:00:00 PR Newswire
ATLANTA, Jan. 27, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) ("Ameri" or the "Company"), announced today that former CIA Director, the Honorable R. James (Jim) Woolsey, has joined the Company as a strategy consultant. Woolsey will provide Ameri leadership with counsel in the…
   Cannabis M&A: Fyllo Acquires CannaRegs, Jay Pharma Reverse Merges With Ameri Holdings  2020/01/20 19:14:22 Benzinga Feeds
Jay Pharma, an evidence-based pharmaceutical cannabinoid and wellness company focused on cancer, announced last week a reverse merger with Ameri Holdings Inc (NASDAQ: AMRH ). The merger will allow Jay Pharma to expand its body of research and execute on its plans to bring oncology clinicians and researchers together with academic and industry partners to enhance clinically proven products to patients. “In a market that is highly underdeveloped with little clinical data, Jay Pharma stands apart as the only developer of cannabinoid-based therapies exclusively focused on the needs of cancer patients. We are uniquely situated to establish a durable leadership position in a market with explosive growth potential,” said Dave Johnson, Chairman and CEO-elect of Jay Pharma. “Our proposed merger with Ameri Holdings will enable us to support the development of our pipeline of novel cannabinoid combination therapies for hard-to-treat cancers, including glioblastoma multiforme, and, … Full story available on Benzinga.
   Jay Pharma Details Business and Clinical Trials Strategy  2020/02/27 13:00:00 PR Newswire
ATLANTA, Feb. 27, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) (the "Company"), brings to the attention of its shareholders a Letter to Stakeholders and Investor Presentation published by Jay Pharma Inc. ("Jay Pharma") that provides an overview of the Company's commitment to…
   Jay Pharma Appoints Former Mallinckrodt plc Executive as Audit Committee Chair  2020/02/20 13:00:00 PR Newswire
ATLANTA, Feb. 20, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) (the "Company"), brings to the attention of its shareholders a press release issued by Jay Pharma Inc. ("Jay Pharma") today to announce the appointment of George A. Kegler, Jr. to Jay Pharma's Board of Directors…
   Sara Dakar to Join Jay Pharma as Vice President, Product Development  2020/02/18 14:00:00 PR Newswire
ATLANTA, Feb. 18, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) (the "Company"), brings to the attention of its shareholders a press release issued by Jay Pharma Inc. ("Jay Pharma") today to announce the appointment of Sara Dakar as Vice President, Product Development. In her…
   Former CIA Director R. James Woolsey Joins AMERI Holdings As Strategy Consultant, Expects To Join Jay Pharma Board Of Directors Upon Closing Of Merger  2020/01/27 13:00:00 PR Newswire
ATLANTA, Jan. 27, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) ("Ameri" or the "Company"), announced today that former CIA Director, the Honorable R. James (Jim) Woolsey, has joined the Company as a strategy consultant. Woolsey will provide Ameri leadership with counsel in the…
   Cannabis M&A: Fyllo Acquires CannaRegs, Jay Pharma Reverse Merges With Ameri Holdings  2020/01/20 19:14:22 Benzinga Feeds
Jay Pharma, an evidence-based pharmaceutical cannabinoid and wellness company focused on cancer, announced last week a reverse merger with Ameri Holdings Inc (NASDAQ: AMRH ). The merger will allow Jay Pharma to expand its body of research and execute on its plans to bring oncology clinicians and researchers together with academic and industry partners to enhance clinically proven products to patients. “In a market that is highly underdeveloped with little clinical data, Jay Pharma stands apart as the only developer of cannabinoid-based therapies exclusively focused on the needs of cancer patients. We are uniquely situated to establish a durable leadership position in a market with explosive growth potential,” said Dave Johnson, Chairman and CEO-elect of Jay Pharma. “Our proposed merger with Ameri Holdings will enable us to support the development of our pipeline of novel cannabinoid combination therapies for hard-to-treat cancers, including glioblastoma multiforme, and, … Full story available on Benzinga.

 関連キーワード  (ITサ―ビス_コンサルティング 米国株 アメリ・ホ―ルディングス AMRH Ameri Holdings Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)